Nucleic acid integration in eukaryotes
CA 2432717 A1 · Owner: Universiteit Leiden · Inventors: Hooykaas, Paul Jan Jacob; Van Attikum, Haico; Bundock, Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relate to the field of molecular biology and cell biology. It particularly relates to methods to direct integration of a nucleic acid of interest towards homologous recombination and uses thereof. The present invention discloses factors involved in integration of a nucleic acid by illegitimate recombination which provides a method to direct integration of a nucleic acid of interest to a pre-determined site whereby said nucleic acid , has homology at or around the said pre-determined site in a eukaryote with a , preference for non-homologous recombination comprising steering an integration pathway towards homologous recombination. Furthermore the invention provides , a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 21, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 21, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 21, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.